A link to the TRS/ABOM Scientific Meeting will be sent via email to registered virtual presenters and attendees a week before the Meeting. You must register individually in order to receive access to the 2022 TRS/ABOM Meeting.
This symposium will be closed to only registered participants with a limitation of only 200 guests. There will be no recording, pictures, distribution or publication of any abstracts or slides unless the presenter approves to do so. This is meant to be a safe place to share confidential information in order to encourage advances in the science of translational research for Angelman syndrome including proof-of-concept data on therapeutics to biomarkers and outcome measures to be used in a clinical trial setting for Angelman syndrome.
Oral presentations and a single slide brief communications/posters will be presented, as well as some round table discussions. Please contact us with any questions about the event. We are so excited to “see” you all in December, and continue to make progress toward meaningful therapeutics for those living with Angelman syndrome.
COVID-19 GUIDELINES: The safety of our community is our top priority. We are continually monitoring recommendations from local, national and international health authorities. Currently, FAST is requiring individuals test negative for SARS-CoV-2 using the rapid antigen test within 24 hours prior to attending the Global Science Summit & Gala. FAST reserves the right to evaluate and expand COVID-19 protocols as best practices and applicable legal requirements evolve.
(Foundation for Angelman Syndrome Therapeutics)